XClose

Division of Infection and Immunity

Home
Menu

Study shows immune response to particular antigenic domain of CMV glycoprotein B

23 March 2018

Dr Ilona Baraniak, a Research Associate in the Griffiths-Reeves CMV team, recently published a paper in the Journal of Infectious Diseases.

Cytomegalovirus infection | By Yale Rosen [CC BY-SA 2.0], via Wikimedia Commons

The paper, 'Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine with MF59: Anti-AD2 Levels Correlate with Protection from Viremia', shows the immune response to a particular antigenic domain of CMV glycoprotein B as the explanation for the partial protection seen against CMV infection in transplant patients during a randomised controlled trial conducted at the Royal Free.

Dr Baraniak's article was selected to have an accompanying editorial.

Links

 Image